Fifth Circuit Blocks Mifepristone Mail Access, Drugmakers Rush to Supreme CourtMay 14, 2026Legal NewsThe Fifth Circuit ordered the FDA to reinstate in-person dispensing rules for mifepristone, blocking mail and telehealth access nationally. Drugmakers filed emergency Supreme Court applications.